chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for Covid after the vaccine; mild cold symptoms; runny nose; This is a spontaneous report from a contactable consumer (patient itself). A 63-years-old male patient received BNT162B2(Solution for injection, Lot Number: EL1283 and Expiration date was unknown), via an unspecified route of administration, administered in Arm Left on 19Feb2021 as SINGLE DOSE for covid-19 immunisation. Medical history included type 2 diabetes mellitus from 2011 and ongoing as he was diagnosed with type II diabetes 10 years ago. The patient's concomitant medications were not reported. Patient stated that he is on other medications for diabetes and that he is due for second shot in two weeks and does not know what to do when it comes. The patient tested positive for covid after the vaccine on 25Feb2021 , mild cold symptoms and runny nose on 19Feb2021. Seriousness of all the events were resported as non-serious. The patient underwent lab tests and procedures which included covid test: positive on 25Feb2021. Outcome of all the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Severe, vision altering headache; severe low back pain; fever; wheezing, SOB lasting 8 hours
Headache; Mental foggy; body aches; tired; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular in right arm on 06Jan2021 H 05:00 PM at single dose for COVID-19 immunization, lot number: EL3246. Medical history was reported as none. Patient had no known allergies and had no COVID prior vaccination. Patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications received within 2 weeks of vaccination included Antibiotic. On 07Jan2021 at 09:00 AM patient experienced headache, mental foggy, body aches and tired. She was not treated for the events. Patient had not been tested for COVID-19 post vaccination. Patient was recovering from the events at the time of the report.  No follow up attempts are possible. No further information is expected.
HIGH BLOOD PRESSURE, STOPPED BREATHING, Erectile Dysfunction, Low Testosterone, Ankylosing Spondylitis, Degenerative Disc Disease, Fibromyalgia.
Pt recv vax on 3/24/99; on 3/29/99 pt exp pain/ heat/hard/ tight left arm
This spontaneous report as received from a pharmacist refers to a 70 years old male patient. The patient was vaccinated with lot # (672932/0599AE) and EXP#(22-JUN-2013) ZOSTAVAX (dose/frequency and route were unspecified) on 05-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. On 11-JUL-2012, the pharmacist stated that a patient had developed a rash on his hands with "little bumps" since the ZOSTAVAX was given. VZV pachet had been faxed. The patient had sought medical attention via visiting pharmacist. No treatment information was reported. The outcome was reported as not recovered/not resolved. Additional information has been requested.
He received his 6 month vaccine on 7/23/12 the rash developed 7/25. He developed generalized hives including head, face, back, chest. His eyes were slightly erythematous as well. No wheezing. Oral steroids and antihistamine provided. Referred to allergist.
On October 11th of 2021 I had my first seizure. I have been having seizures ever since. Around January 2022, I started noticing that my heart rate would rapidly increase while lying in bed doing nothing. I have started having dizzy spells and other issues relating to the heart issues I am now experiencing.
Headache; pain/warmth at injection site; pain/warmth at injection site; nightmares; This is a spontaneous report from a non-contactable other health care professional. A 30-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: lot number: EL0142), via an unspecified route of administration on 07Jan2021 at SINGLE DOSE at right arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient previously took amoxicillin and Aspirin; and experienced allergies. On 07Jan2021, the patient experienced headache, pain/warmth at injection site, and nightmares. The outcome of the events was recovered. The patient took some ibuprofen as treatment.     No follow up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable pharmacist (patient) received via a sales representative. A female patient of an unspecified age received the third dose of TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first and second dose of TRUMENBA on an unspecified date for immunization. The received third dose of meningococcal group b rlp2086 vaccine and was in bed for three days with a fever. The outcome of the event was unknown. Information on the lot number has been requested.
No adverse event; Patient DOB is 08-JUN-2021 and she received PROQUAD on 25-JUN-2021; Incorrect product storage; This spontaneous report was received from a medical assisstant and refers to a 17-days-old female patient. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 25-JUN-2021, the patient was vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dosage regimen and route of administration were not reported), lot numbers reported to suffer temperature excursion were T014388, T025221 (rHA) and T027115 (rHA) and respective expiration dates 24-OCT-2021, 19-JAN-2022 and 02-FEB-2022 (It was not specified which lot was administered to the patient) administered as prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion unknown by the reporter for an unknown timeframe; it was also unknown if there were previous temperature excursions.  No adverse symptoms were reported.  This one of several cases from the same reporter.; Sender's Comments:  US-009507513-2106USA007465: US-009507513-2107USA006276:
Presented febrile with temperature 101.9 degrees, pulse rate of 93, respiratory rate of 30, blood pressure of 138/80, saturating 90% on room air, COVID-19 testing  positive. Reports  was dx with COVID on 8/20 but has had sx since 8/18. COVID 19 Pneumonia - on dexamethasone ,per ID outside window for Remdesivr . Completed COVID Vaccine 3/15/2021 -Her symptoms improved and she was dc home
Itchy rash over abdomen, chest and leg (left side of body) began 7 days after vaccine. Applied sterroid cream. Rash continues to errupt 2 1/2 weeks after vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 at 09:00 as dose 5 (booster), single (Lot number: GH9694) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Lot number: FJ9943), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 13Jan2023 to 28Jan2023.
I was contacted by VSAFE and told to file a VAERS report due to being diagnosed with COVID-19 on 9/7/21.
Fever low grade 100.4; headache; body aches; slept a lot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept a lot), PYREXIA (Fever low grade 100.4), HEADACHE (headache) and MYALGIA (body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (Fever low grade 100.4), HEADACHE (headache) and MYALGIA (body aches). In February 2021, the patient experienced HYPERSOMNIA (slept a lot). On 12-Feb-2021, PYREXIA (Fever low grade 100.4) outcome was unknown, HEADACHE (headache) and MYALGIA (body aches) had resolved. In February 2021, HYPERSOMNIA (slept a lot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment information not provided
tiny bit of dizziness, felt like everything was going dark; This is a spontaneous report from a contactable Consumer. A 78-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL0140; Expiration Date: 31Mar2021) via intramuscular route administered in left deltoid on 14Jan2021 12:41 as single dose (0.3mL) for COVID-19 immunization. Medical history included atrial fibrillation and blood pressure high. She was on medication for this condition. The patient's concomitant medications were not reported. No prior vaccinations within 4 weeks. The patient experienced tiny bit of dizziness, felt like everything was going dark on 14Jan2021. Caller stated that she received the second COVID-19 vaccine. She was scheduled to receive her second vaccine and she doesn't know whether or not to do it. Caller explains she had the shot, and her facility had her wait 15 minutes. She didn't think much about it. She went to the bathroom to kill some time. It was about 1 minute until it was time to leave, and she was getting her husband gathered up so by the time they got to the door, she could probably leave. Very quickly she had this tiny bit of dizziness and it felt like everything was going dark. She states this episode was very quick and didn't last long at all. After that, she was totally fine. She doesn't know whether to have her second vaccine or not. No relevant tests done. The outcome of the event was recovered.  Follow-up attempts are completed. No further information is expected.
Both knees started aching, they were painful at the same time and My knee still aches at times in the beginning it was very painful and it is less painful today; This is a spontaneous report from a contactable consumer (patient). A 80-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection Batch/lot number: Unknown and expiry date was not provided), via an unspecified route of administration, in the left arm, on 05Apr2021 at 13:10 (at the age of 80-years-old) as a single dose for covid-19 immunisation. Medical history and concomitant medication were not reported. Patient had previously taken first dose of vaccine on 14Mar2021 at 10:00. No other vaccine has been administered within 4 weeks prior to COVID shot. On 19Apr2021, patient had both knees started aching, they were painful at the same time and for his knee still aches at times in the beginning it was very painful and it was less painful today. They slowly started getting better but they aren't 100 percent yet patient was little concerned that will never get back to normal. Patient still experiencing less pain, both knees are the same slightly improved but not completely. On 18May2021, patient had complete blood count as routine lab tests and result was normal. Reporter seriousness for both knees started aching, they were painful at the same time and for my knee still aches at times in the beginning it was very painful and it was less painful today was unspecified. No treatment was received. The outcome of event was recovering.   Information about batch/lot number has been requested.
Pulmonary embolism.  Admitted 4/16 overnight for chest pain.  Found to have PE.
I woke up with a sore throat, chills, cough, felt weak, the first few days was a blur. I tested positive for COVID-19. I talked to my doctor and prescribed me PAXLOVID. I still have a cough but I feel way better now and I am negative.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Nov2021 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 49 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hairy cell leukemia" (unspecified if ongoing); "osteopenia" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "Known allergies: Sulfa based medication" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO; CALCIUM; MAGNESIUM; VITAMIN D [VITAMIN D NOS]. Past drug history included: Zofran, reaction(s): "allergies"; Phenergen, reaction(s): "allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Jul2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Negative; (20Jul2022) Positive, notes: On day 11.  Clinical course: The vaccine lot was unknown as it was not available/provided to reporter at the time of report completion. Patient took Paxlovid from 10Jul2022 to 14Jul2022 for treatment of COVID-19. She took the medication for 5 days and then tested negative. On day 11 she woke up very congested and took a rapid test and it was very positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Muscle and joint pain; Muscle and joint pain; Achy all day; This is a spontaneous report received from a contactable nurse (patient herself). An unspecified aged female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection) via an unspecified route of administration on 30Jan2021 at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. . Patient stated that, "she doesn't see any expiration date on it. LOT# is PF1 (incomplete sentence) it just says Pfizer. It just says Covid-19 Pfizer and the date on it Jan2021. On 03Feb2021 patient was reported as she had the Covid Vaccine on Saturday and she had been experienced a lot of muscle and joint pain today." She was just wondering, she guess it is okay to get her second shot which would be like in 3 weeks." She further stated about causality that, she was not 100 percent sure. She thinks it was because you know she was achy all day today". The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A few hours after vaccine administered, very sudden shooting pain in left arm & under arm (arm pit area), could not raise arm.  Later followed by diarrhea, vomiting, pain in abdomen, muscle spasms.  Following day - still painful & still nauseous.
This spontaneous report as received from a Registered Nurse regarding a 4 year old child patient of unknown gender. There was no information about concurrent condition, historical medication and concomitant medication. On 18-SEP-2018, the patient was vaccinated with improperly stored PROQUAD for prophylaxis (product storage error). Vaccine was stored out of range at -6 degrees for an approximate time of 15 minutes. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA001085.
Pain in right thigh, SOB, O2 SAT 76%, T-100.7
Contacted client's mother on 10/28/20 and received verbal consent to administer Tdap and meningococcal conjugate vaccines. On 11/11/2020, this RN prepared the vaccinations and administered Boostrix and Menactra. Upon rereivew of registry, documentation noted that client had received Tdap on 06/30/2020. Contacted client's mother to notify her of immunization error and education provided on potential side effects. Client's mother denied that client had redness or local reaction at injection site but did state that client's arm was mildly sore. Client's mother stated she had forgotten client received a Tdap vaccine on 06/30/2020 due to getting stitches. Client's mother denied questions or concerns.
Within about 15 minutes, had onset of hives on lower right eyelid, itchy eyes, cough and sneezing. Size of hives rapidly progressive. No wheeze/lip swelling/facial swelling. Did not develop hives elsewhere (with ?hurt lower left eyelid). Given po Benadryl and SQ epi in office.
p/vax pt began wheezing, coughing & face became puffy in the PM;pt had hives & red rash on face, back & stomach;states child throat felt like something was in it;taken to ER on 3/24/99 & dx w/alleged allergic rxn;
attempted to give janssen covid immunization to customer and upon needle injection, realized I has forgotten to fill syringe with medicine. I apologized and gave shot with janssen medicine.
Patient recommended to remain seated for 15 minutes after administration of vaccination. Immediately after administering and for a few minutes following she stated she feels fine, however about 15 minutes post-administration she stated feeling dizzy and with a headache. She was recommended to remain seated longer, asked if she were diabetic, she stated no; she did say she hadn't eaten lunch, we asked if she'd like something to drink, and she requested orange juice so we provided this; we f/u with guest in an hour to check on how she's doing and stated her symptoms subsided and she's doing well.
right side under her eye was swollen; right side of face was swollen; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date unknown) via an unspecified route of administration on the right arm on 12Jan2021 at a single dose for COVID-19 immunization. The patient had no relevant medical history and no concomitant medications. The patient reported she had the first shot on yesterday (12Jan2021); it was given by a nurse at the hospital where she works. Last night, she noticed on the same side that she got shot, her right side under her eye was swollen and the right side of her face was swollen too. She wanted to know what to do and wanted to know if they were side effects. No therapeutics measures were done in response to the events. At the time of last observation, events' outcome was not recovered.  Information about Lot/Batch number is requested.
CHILLS; NAUSEA; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced chills, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea and chills was not reported. This report was non-serious.
Oct 23 flu shot followed by my usual reaction: low grade fever and malaise x 2 days and shortly after relatively severe increased back pain radiating through groin and legs and pain in upper body arms/ shoulders, tenderness in my spinous processes in lower back. This pattern continues every day, this kind of widespread pain in the morning where I have trouble putting on shoes or picking up things on the floor. It gradually improves with exercise throughout the day although the back pain remains a dull ache.  Pain is steady, not a shooting nerve type.  Yoga, back exercises, heat, massage and Aleve help. Treated with Tylenol, meloxicam with improvement over 1 week
Cough, aches then lung, sinus & larynx infection.  Trouble clearing lungs, laryngitis. Still some symptoms, though recovering after 6 days.
Patient states within 24 hours after receiving the vaccine he experience itching all over his body with no rash and a runny nose.  He states he has been getting Fluzone HD in previous years with no issue. Patient states after 2-3 days he has gotten better.
Can't raise his arm over his shoulder; It feels excruciating to move arm/If he lifts his arm, it hurts/; if he lays down; Feels pain from that injection site from the first shot today/ was piercing and it hurt/ it got progressively worse; Injected right into the socket between the upper arm and shoulder/been having pain in that socket; injected right into the socket between the upper arm and shoulder; Soreness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Can't raise his arm over his shoulder), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected right into the socket between the upper arm and shoulder), PAIN (Soreness), PAIN (It feels excruciating to move arm/If he lifts his arm, it hurts/; if he lays down) and INJECTION SITE PAIN (Feels pain from that injection site from the first shot today/ was piercing and it hurt/ it got progressively worse) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected right into the socket between the upper arm and shoulder). On an unknown date, the patient experienced HYPOKINESIA (Can't raise his arm over his shoulder), PAIN (Soreness), PAIN (It feels excruciating to move arm/If he lifts his arm, it hurts/; if he lays down), INJECTION SITE PAIN (Feels pain from that injection site from the first shot today/ was piercing and it hurt/ it got progressively worse), PYREXIA (Fever) and ARTHRALGIA (Injected right into the socket between the upper arm and shoulder/been having pain in that socket). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN (ADVIL PM [DIPHENHYDRAMINE HYDROCHLORIDE;IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 20-Apr-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected right into the socket between the upper arm and shoulder) had resolved. At the time of the report, HYPOKINESIA (Can't raise his arm over his shoulder) outcome was unknown, PAIN (Soreness) and PYREXIA (Fever) had resolved and PAIN (It feels excruciating to move arm/If he lifts his arm, it hurts/; if he lays down), INJECTION SITE PAIN (Feels pain from that injection site from the first shot today/ was piercing and it hurt/ it got progressively worse) and ARTHRALGIA (Injected right into the socket between the upper arm and shoulder/been having pain in that socket) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported.